Author

Charlotte Neuerburg

Observed name: Charlotte K.F. Neuerburg

Institution: University Hospital Bonn

Observed institutions: University of Bonn, University Hospital Bonn

ORCID: 0009-0009-3134-9567

Observed ORCID: 0009-0009-3134-9567

OpenAlex ID: A5029188372

Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia

2021 · Christina Rautenberg, Friedrich Stölzel, et al. · Blood Cancer Journal · 64

Antibiotic Prophylaxis During Allogeneic Stem Cell transplantation—A Comprehensive Single Center Retrospective Analysis

2024 · Charlotte K.F. Neuerburg, Friederike Schmitz, et al. · Transplantation and Cellular Therapy · 13

Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia – long-term follow-up with focus on younger patients

2025 · Christina Rautenberg, Jan Moritz Middeke, et al. · Blood Cancer Journal · 6

Real-World Experience of CPX-351 As First-Line Treatment in 188 Patients with Acute Myeloid Leukemia

2021 · Christina Rautenberg, Friedrich Stölzel, et al. · Blood · 3

Treatment of Severe Acute Graft-Versus-Host Disease Refractory to Multiple Lines of Therapy: Real-World Data from 317 Adults Treated with the Multiple-Donor Bone Marrow-Derived Mesenchymal Stromal Cell Preparation Tomostrocel

2026 · Mareike Verbeek, Halvard Bonig, et al. · Transplantation and Cellular Therapy

The Potential of E-Health in Patients after Allogeneic Stem Cell Transplantation

2022 · Friederike Schmitz, Charlotte Neuerburg, et al. · Blood

Works count: 6

Citation count: 86

H-index: 3

I10-index: 2